AI in Rare Disease Trials | Scott Schliebner
Rare disease clinical trials present a problem unlike almost anything else in drug development: how do you run a rigorous trial when the patients you need may be exceptionally difficult to find?
Scott Schliebner joins BioTalk Unzipped to explore rare disease development, clinical research, artificial intelligence, and the operational realities of building organizations across international boundaries.
The episode begins with a discussion of Rare Givers, an organization supporting caregivers in the rare disease community.
Scott then explains what led him into clinical research before the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.